Search Results - "Wondergem, Mariëlle"

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study by Brink, Mirian, Meeuwes, Frederik O., van der Poel, Marjolein W.M., Kersten, Marie José, Wondergem, Mariëlle, Mutsaers, Pim G.N.J., Böhmer, Lara H., Woei-A-Jin, F. J. Sherida H., Visser, Otto, Oostvogels, Rimke, Jansen, Patty M., Plattel, Wouter, Huls, Gerwin A., Vermaat, Joost S.P., Nijland, Marcel

“…Patients aged <65 years with peripheral T-cell lymphoma (PTCL) are treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Although the…”
Get full text

High‐dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma by Aydin, Mesire, Tang, Man Wai, Wondergem, Mariëlle J., Leeuw, David C., Wegman, Jurgen J., Biemond, Bart J., Donk, Niels W. C. J., Zweegman, Sonja, Meijer, Ellen, Nur, Erfan

Get full text

Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial by Veringa, Anette, Brüggemann, Roger J., Span, Lambert F.R., Biemond, Bart J., de Boer, Mark G.J., van den Heuvel, Edwin R., Klein, Saskia K., Kraemer, Doris, Minnema, Monique C., Prakken, Niek H.J., Rijnders, Bart J.A., Swen, Jesse J., Verweij, Paul E., Wondergem, Mariëlle J., Ypma, Paula F., Blijlevens, Nicole, Kosterink, Jos G.W., van der Werf, Tjip S., Alffenaar, Jan-Willem C.

“…•80.9% of all haematological patients with invasive aspergillosis had an initial voriconazole concentration (measured around 3 days after treatment initiation)…”
Get full text

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias by Cremers, Eline M.P, Westers, Theresia M, Alhan, Canan, Cali, Claudia, Wondergem, Mariëlle J, Poddighe, Pino J, Ossenkoppele, Gert J, van de Loosdrecht, Arjan A

“…Abstract Mandatory for the diagnosis of myelodysplastic syndromes (MDS) is the presence of dysplasia in >10% of cells within one or more cell lineages or…”
Get full text

Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands by Meeuwes, Frederik O, Brink, Mirian, Plattel, Wouter, Van der Poel, Marjolein W M, Kersten, Marie José, Wondergem, Mariëlle, Böhmer, Lara, Woei-A-Jin, F J Sherida H, Visser, Otto, Oostvogels, Rimke, Jansen, Patty M, Neelis, Karen J, Crijns, Anne P G, Daniëls, Laurien A, Snijders, Tjeerd J F, Vermaat, Joost S P, Huls, Gerwin A, Nijland, Marcel

“…Peripheral T-cell lymphomas (PTCL) comprise a heterogeneous group of mature T-cell neoplasms with an unfavorable prognosis; presentation with stage I(E)…”
Get full text

The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile? by van Spronsen, Margot F, Westers, Theresia M, Lissenberg-Witte, Birgit I, Wondergem, Mariëlle, Ossenkoppele, Gert J, van de Loosdrecht, Arjan A

Get full text

Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis by Meeuwes, Frederik O., Brink, Mirian, van der Poel, Marjolein W.M., Kersten, Marie José, Wondergem, Mariëlle, Mutsaers, Pim G.N.J., Böhmer, Lara, Woei-A-Jin, Sherida, Visser, Otto, Oostvogels, Rimke, Jansen, Patty M., Diepstra, Arjan, Snijders, Tjeerd J.F., Plattel, Wouter J., Huls, Gerwin A., Vermaat, Joost S.P., Nijland, Marcel

“…Patients with angioimmunoblastic T-cell lymphoma (AITL) are treated with cyclophosphamide, doxorubicin, vincristine and prednisone with or without etoposide…”
Get full text

Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study by Slot, Stefanie, Lavini, Cristina, Zwezerijnen, Gerben J C, Boden, Bouke J H, Marcus, J Tim, Huisman, Marc C, Yaqub, Maqsood, Barbé, Ellis, Wondergem, Mariëlle J, Zijlstra, Josée M, Zweegman, Sonja, Raijmakers, Pieter G

“…Current diagnostic criteria for myelofibrosis are largely based on bone marrow (BM) biopsy results. However, these have several limitations, including sampling…”
Get full text

Baseline and longitudinal variability of normal tissue uptake values of [18 F]-fluorothymidine-PET images by Cysouw, Matthijs C.F, Kramer, Gerbrand M, Frings, Virginie, De Langen, Adrianus J, Wondergem, Mariëlle J, Kenny, Laura M, Aboagye, Eric O, Kobe, Carsten, Wolf, Jürgen, Hoekstra, Otto S, Boellaard, Ronald

“…Abstract Purpose [18 F]-fluorothymidine ([18 F]-FLT) is a PET-tracer enabling in-vivo visualization and quantification of tumor cell proliferation. For…”
Get full text

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis by Mascarenhas, John, Kremyanskaya, Marina, Patriarca, Andrea, Palandri, Francesca, Devos, Timothy, Passamonti, Francesco, Rampal, Raajit K, Mead, Adam J, Hobbs, Gabriella, Scandura, Joseph M, Talpaz, Moshe, Granacher, Nikki, Somervaille, Tim C P, Hoffman, Ronald, Wondergem, Marielle J, Salama, Mohamed E, Colak, Gozde, Cui, Jike, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M, Verstovsek, Srdan, Curto-García, Natalia, Harrison, Claire, Gupta, Vikas

“…Standard therapy for myelofibrosis comprises Janus kinase inhibitors (JAKis), yet spleen response rates of 30%-40%, high discontinuation rates, and a lack of…”
Get full text

A Patient with a Prolonged Activated Partial Thromboplastin Time and a Deep Intracerebral Haemorrhage by Schindhelm, Roger K., Wondergem, Mariëlle J., Admiraal, Joke, Nap, Gert, ten Boekel, Edwin, Hani, Lahcen

“…We report on a 57-year-old woman with a pontine haemorrhage and an extremely prolonged activated partial thromboplastin time (aPTT) of more than 240 s,…”
Get full text

Transfusion of ever-pregnant donor red blood cells and mortality of male patients by Valk, Sarah J, Caram-Deelder, Camila, Groenwold, Rolf H H, Evers, Dorothea, De Vooght, Karen M K, Van de Kerkhof, Daan, Wondergem, Marielle J, Péquériaux, Nathalie C V, Hudig, Francisca, Zwaginga, Jaap Jan, Middelburg, Rutger A, Van der Bom, Johanna G

“…Previous studies found exposure to red blood cell transfusions from female donors who have been pregnant reduces survival in male patients compared to exposure…”
Get full text

Severe Tissue Necrosis after Low-Concentration Cisplatin Extravasation: A Case Report and Review of Expert Guidelines and Literature by Braam, Anouk M., Wondergem, Mariëlle, Crul, Mirjam

“…A 65-year-old man was treated with a course of rituximab, cisplatin, and cytarabine. During the second cycle, a volume of 40–50 mL of 0.3 mg/mL cisplatin was…”
Get full text

Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis by Harrison, Claire N, Gupta, Vikas K, Gerds, Aaron T, Rampal, Raajit, Verstovsek, Srdan, Talpaz, Moshe, Kiladjian, Jean-Jacques, Mesa, Ruben, Kuykendall, Andrew T, Vannucchi, Alessandro M, Palandri, Francesca, Grosicki, Sebastian, Devos, Timothy, Jourdan, Eric, Wondergem, Marielle J, Al-Ali, Haifa Kathrin, Buxhofer-Ausch, Veronika, Alvarez-Larrán, Alberto, Patriarca, Andrea, Kremyanskaya, Marina, Mead, Adam J, Akhani, Sanjay, Sheikine, Yuri, Colak, Gozde, Mascarenhas, John

“…Myelofibrosis (MF) is a clonal myeloproliferative neoplasm, typically associated with disease-related symptoms, splenomegaly, cytopenias and bone marrow…”
Get full text

Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma by Alonso-Álvarez, Sara, Manni, Martina, Montoto, Silvia, Sarkozy, Clémentine, Morschhauser, Franck, Wondergem, Marielle J., Guarini, Attilio, Magnano, Laura, Alcoceba, Miguel, Chamuleau, Martine, Galimberti, Sara, Gomes da Silva, Maria, Holte, Harald, Zucca, Emanuele, Lockmer, Sandra, Aurer, Igor, Marcheselli, Luigi, Stepanishyna, Yana, Caballero Barrigón, María Dolores, Salles, Gilles, Federico, Massimo

“…Primary refractory (PREF) follicular lymphoma (FL) has a completely different clinical course from that of FL that responds to front-line treatments. In…”
Get full text

A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands by Issa, Djamila E., Dinmohamed, Avinash G., Wondergem, Marielle J., Blommestein, Hedwig M., Huijgens, Peter C., Lugtenburg, Pieternella J., Visser, Otto, Zweegman, Sonja, Chamuleau, Martine E. D.

“…Randomized controlled trials have studied different dose-intensity and dose-interval regimens of R-CHOP for patients with diffuse large B-cell lymphoma…”
Get full text

An Acute Promyelocytic Leukemia Resistant to All-Trans Retinoic Acid: A Case Report of the ZBTB16::RARa Variant and Review of the Literature by Castelijn, Daan A.R., Sijm, Gerrit, Venniker-Punt, Bianca, Poddighe, Pino J., Wondergem, Marielle J.

“…Abstract Introduction: Acute promyelocytic leukemia (APL) is characterized by the PML::RARa gene fusion and treatment consists of all-trans retinoic acid…”
Get full text

Donor pregnancies and transfusion recipient mortality: A role for red blood cell storage? by Valk, Sarah J., Caram‐Deelder, Camila, Evers, Dorothea, Vooght, Karen M. K., Kerkhof, Daan, Wondergem, Marielle J., Péquériaux, Nathalie C. V., Hudig, Francisca, Zwaginga, Jaap Jan, Korte, Dirk, Watering, Leo M. G., Middelburg, Rutger A., Bom, Johanna G.

“…Background and Objectives Donor characteristics have been implicated in transfusion‐related adverse events. Uncertainty remains about whether sex, and…”
Get full text

The Progress Test of the European Hematology Association: A New Tool for Continuous Learning by Wondergem, Marielle J., Almeida, Antonio, Brolin, Janaki, Fernandez de Larrea, Carlos, Havre, Nathalie, Hemker, Bas T., Hollegien, Wietske, Navarro, José‐Tomás, Prahladan, Mahesh, Rovó, Alicia, Birgegård, Gunnar

Get full text

Development and testing of a tailored online fertility preservation decision aid for female cancer patients by Berg, Michelle, Meij, Elleke, Bos, Annelies M. E., Boshuizen, Marieke C. S., Determann, Domino, Eekeren, Ramon R. J. P., Lok, Christianne A. R., Schaake, Eva E., Witteveen, Petronella O., Wondergem, Marielle J., Braat, Didi D. M., Beerendonk, Catharina C. M., Hermens, Rosella P. M. G.

“…Background Decision making regarding future fertility can be very difficult for female cancer patients. To support patients in decision making, fertility…”
Get full text